Author

G. Askan

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 2 Approach:statistical model· 2 Assay:ATAC-seq· 1 Research Focus:chromatin & epigenetic regulation· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Research Focus:protein folding & dynamics· 1 Research Focus:variant effect prediction· 1

Frequent Co-Authors

S. D. Leach· 2 shared A. Cardenas· 1 shared A. L. Massa· 1 shared A. P. Makohon-Moore· 1 shared A. Ventura· 1 shared B. Curry· 1 shared C. A. Iacobuzio-Donahue· 1 shared C. S. Leslie· 1 shared

Activity by Year

2020-2021 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 31 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

S. D. Leach

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Pancreatic cancer prognosis is predicted by a novel ATAC-array technology for assessing chromatin accessibility

S. Dhara, S. Chhangawala, H. Chintalapudi, G. Askan, V. Aveson, A. L. Massa, L. Zhang, A. P. Makohon-Moore, N. Lecomte, J. P. Melchor, J. Bermeo, A. Cardenas, S. Sinha, D. Glassman, R. Nicolle, , S. D. Leach

The paper develops ATAC-Array, a low-cost chromatin accessibility assay, and shows it predicts pancreatic cancer prognosis based on chromatin accessibility patterns.

bioRxiv · Jan 21, 2021Cancer Biology

The origins and consequences of UPF1 variants in pancreatic adenosquamous carcinoma

J. T. Polaski, D. B. Udy, L. F. Escobar-Hoyos, G. Askan, S. D. Leach, A. Ventura, R. Kannan, R. K. Bradley

This study investigates UPF1 mutations in pancreatic adenosquamous carcinoma, finding they are likely non-pathogenic and not a common driver of the disease.

bioRxiv · Aug 14, 2020Cancer Biology